SCHEMBL19953073

SCHEMBL19953073

Cc1ccc(F)c(/C=N/c2ccc(Cl)cc2)c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.42
CYP2C19 P33261 2/20 0.42
RECQL P46063 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 6/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.41
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
MAPT P10636 7/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
XBP1 P17861 1/20 0.39
GAA P10253 4/20 0.38
LMNA P02545 4/20 0.38
HTT P42858 2/20 0.38
KDM4E B2RXH2 2/20 0.36
TSHR P16473 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953197 0.86 CYP1A2 (0.46) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19953070 0.83 CYP1A2 (0.44) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19952993 0.83 CYP1A2 (0.44) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19967280 0.80 CYP1A2 (0.42) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19953208 0.80 CA2 (0.43) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19953115 0.80 MAPT (0.48) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL1163846 0.79 CYP1A2 (0.46) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19953160 0.79 CYP1A2 (0.46) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL1163845 0.79 CYP1A2 (0.46) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1
SCHEMBL19952999 0.78 CYP1A2 (0.43) CYP1A2CYP2C19RECQLL3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed